A carregar...
A new design for a chronological release profile of etodolac from coated bilayer tablets: In-vitro and in-vivo assessment
Repeated dose medication usually maximizes adverse effects, while sustained release systems did not offer a fast onset of action. Etodolac was formulated to enable pulsatile and sustained drug release, which was chronologically more suitable as an anti-inflammatory drug. Eudragit® RSPO, Eudragit® RL...
Na minha lista:
| Publicado no: | J Adv Res |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6300462/ https://ncbi.nlm.nih.gov/pubmed/30581611 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jare.2018.08.003 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|